News

CLINUVEL
Posted by CLINUVEL
November 27, 2017

Results of Meeting

27  November 2017 In accordance with Listing Rule 3.13.2 and section 251AA...

Read More
CLINUVEL
Posted by CLINUVEL
November 27, 2017

Managing Director's AGM Presentation

27 November 2017 Today’s discussion outlines the CLINUVEL Board’s objectives to lead...

Read More
CLINUVEL
Posted by CLINUVEL
November 27, 2017

Chair's Address to the Annual General Meeting

28 November 2017 Coming from the background of an ethical pharmaceutical company...

Read More
CLINUVEL
Posted by CLINUVEL
November 7, 2017

Response to ASX Price Query

07 November 2018 Enclosed is the response of CLINUVEL PHARMACEUTICALS LTD in...

Read More
CLINUVEL
Posted by CLINUVEL
October 29, 2017

Appendix 4C

29 October 2017 CLINUVEL PHARMACEUTICALS LTD (ASX: CUV; XETRA-DAX: UR9; NASDAQ INTERNATIONAL...

Read More
CLINUVEL
Posted by CLINUVEL
October 26, 2017

Notice of Annual General Meeting/Proxy Form

26 October 2017 This Explanatory Memorandum has been prepared for the Shareholders...

Read More
CLINUVEL
Posted by CLINUVEL
October 26, 2017

Appendix 4G

26 October 2017 This statement reports on the main corporate governance practices...

Read More
CLINUVEL
Posted by CLINUVEL
October 16, 2017

CLINUVEL Newsletter - October 2017

16 October 2017 I am addressing you during quite a turbulent period,...

Read More
CLINUVEL
Posted by CLINUVEL
October 9, 2017

CLINUVEL CONFIRMS AGM DATE

10 October 2017 CLINUVEL PHARMACEUTICALS LTD  today announced it will hold its...

Read More
CLINUVEL
Posted by CLINUVEL
October 4, 2017

ELIE ISHAG TO RETIRE FROM CLINUVEL BOARD

04 October 2017 CLINUVEL PHARMACEUTICALS LTD today announced that Mr Elie Ishag...

Read More